Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 161Neoplasms 118Carcinoma, Non-Small-Cell Lung 92Prostatic Neoplasms 86Colorectal Neoplasms 86Lung Neoplasms 77Leukemia, Myeloid, Acute 53Carcinoma, Hepatocellular 53Pancreatic Neoplasms 46Neoplasm Metastasis 44Multiple Myeloma 39Recurrence 36Triple Negative Breast Neoplasms 32Squamous Cell Carcinoma of Head and Neck 29Ovarian Neoplasms 29Brain Neoplasms 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Melanoma 28Glioblastoma 28Uterine Cervical Neoplasms 27Head and Neck Neoplasms 27Stomach Neoplasms 26Rectal Neoplasms 25Small Cell Lung Carcinoma 23Carcinoma, Renal Cell 22Glioma 21Sarcoma 19Lymphoma, B-Cell 19Endometrial Neoplasms 19Lymphoma, Follicular 18

Interventions

trilaciclib 1Sodium Chloride 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Limited Stage Small Cell Lung Cancer × 90 days × Clear all
NCT07473128 2026-03-16

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Pharmacosmos A/S

Phase 3 Not yet recruiting
120 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡